Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linong Ji

Showing results (51-60 of 587) with videos related to

Pageof 59
Sort By:
Journal of Diabetes|August 8, 2019
Early life exposure to 1959-1961 Chinese famine exacerbates association between diabetes and cardiovascular diseaseZumin Shi, Linong Ji, Ronald C W Ma, et al.
Diabetes & Metabolism Journal|March 11, 2021
Non-Insulin Antidiabetes Treatment in Type 1 Diabetes Mellitus: A Systematic Review and Meta-AnalysisXiaoling Cai, Chu Lin, Wenjia Yang, et al.
Pharmaceuticals (Basel, Switzerland)|January 28, 2026
Factors Affecting the Treatment Heterogeneity of PPARγ and Pan-PPAR Agonists in Type 2 Diabetes Mellitus: A Systematic Review and Machine Learning-Based Meta-Regression AnalysisXinlei Zhang, Yingning Liu, Ming Chu, et al.
BMC Medicine|July 21, 2025
Trajectory of the body weight after drug discontinuation in the treatment of anti-obesity medicationsHan Wu, Wenjia Yang, Tong Guo, et al.
JACC. Asia|January 31, 2025
Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in 3 Chinese CohortsQi Huang, Yufeng Li, Xianghai Zhou, et al.
Journal of Diabetes Research|August 10, 2019
Risk of Malignant Neoplasia with Glucagon-Like Peptide-1 Receptor Agonist Treatment in Patients with Type 2 Diabetes: A Meta-AnalysisYufang Liu, Xiaomei Zhang, Sanbao Chai, et al.
Zhonghua Nei Ke Za Zhi|September 12, 2015
[Effectiveness and safety of initiation of once-daily insulin detemir in Chinese patients with type 2 diabetes previously treated with different quantities of oral anti-diabetic drugs: subgroup analysis of the Chinese SOLVE™ Study]Changyu Pan, Linong Ji, Juming Lu, et al.
Journal of Diabetes Investigation|February 6, 2020
Silent hemoglobin variant during capillary electrophoresis: A case reportYanping Yuan, Xianghai Zhou, Leili Gao, et al.
The Lancet. Diabetes & Endocrinology|October 26, 2023
Explaining the high rate of progression from prediabetes to type 2 diabetes in China - Authors' replyLihui Zhang, Qiuhong Gong, Ningling Sun, et al.
Diabetes/Metabolism Research and Reviews|August 3, 2020
Dipeptidyl peptidase-4 inhibitor treatment and the risk of bullous pemphigoid and skin-related adverse events: A systematic review and meta-analysis of randomized controlled trialsWenjia Yang, Xiaoling Cai, Simin Zhang, et al.
Pageof 59

Showing results (51-60 of 587) with videos related to

Sort By:
Pageof 59
Journal of Diabetes|August 8, 2019
Early life exposure to 1959-1961 Chinese famine exacerbates association between diabetes and cardiovascular diseaseZumin Shi, Linong Ji, Ronald C W Ma, et al.
Diabetes & Metabolism Journal|March 11, 2021
Non-Insulin Antidiabetes Treatment in Type 1 Diabetes Mellitus: A Systematic Review and Meta-AnalysisXiaoling Cai, Chu Lin, Wenjia Yang, et al.
Pharmaceuticals (Basel, Switzerland)|January 28, 2026
Factors Affecting the Treatment Heterogeneity of PPARγ and Pan-PPAR Agonists in Type 2 Diabetes Mellitus: A Systematic Review and Machine Learning-Based Meta-Regression AnalysisXinlei Zhang, Yingning Liu, Ming Chu, et al.
BMC Medicine|July 21, 2025
Trajectory of the body weight after drug discontinuation in the treatment of anti-obesity medicationsHan Wu, Wenjia Yang, Tong Guo, et al.
JACC. Asia|January 31, 2025
Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in 3 Chinese CohortsQi Huang, Yufeng Li, Xianghai Zhou, et al.
Journal of Diabetes Research|August 10, 2019
Risk of Malignant Neoplasia with Glucagon-Like Peptide-1 Receptor Agonist Treatment in Patients with Type 2 Diabetes: A Meta-AnalysisYufang Liu, Xiaomei Zhang, Sanbao Chai, et al.
Zhonghua Nei Ke Za Zhi|September 12, 2015
[Effectiveness and safety of initiation of once-daily insulin detemir in Chinese patients with type 2 diabetes previously treated with different quantities of oral anti-diabetic drugs: subgroup analysis of the Chinese SOLVE™ Study]Changyu Pan, Linong Ji, Juming Lu, et al.
Journal of Diabetes Investigation|February 6, 2020
Silent hemoglobin variant during capillary electrophoresis: A case reportYanping Yuan, Xianghai Zhou, Leili Gao, et al.
The Lancet. Diabetes & Endocrinology|October 26, 2023
Explaining the high rate of progression from prediabetes to type 2 diabetes in China - Authors' replyLihui Zhang, Qiuhong Gong, Ningling Sun, et al.
Diabetes/Metabolism Research and Reviews|August 3, 2020
Dipeptidyl peptidase-4 inhibitor treatment and the risk of bullous pemphigoid and skin-related adverse events: A systematic review and meta-analysis of randomized controlled trialsWenjia Yang, Xiaoling Cai, Simin Zhang, et al.
Pageof 59